New nasal spray protects against COVID-19, common cold
29 March, 2021A new drug, designed to prime the immune system in the respiratory tract and currently in development for COVID-19, is also effective against rhinovirus.
Anti-inflammatory may help reduce chemo side effects
16 March, 2021Researchers have found that the anti-inflammatory drug anakinra substantially reduces the nerve symptoms for which vincristine chemotherapy is known.
Novavax vaccine efficacious against multiple COVID-19 strains
15 March, 2021Novavax has announced final efficacy of 96.4% against mild, moderate and severe disease caused by the original COVID-19 strain.
CSIRO secures a licence to develop medicinal cannabis
08 March, 2021The licence places CSIRO at the forefront of research into the development of new cannabis medicines, which should help people with a variety of conditions.
Dual-targeting drug developed for EBV-related cancers
05 March, 2021Hong Kong researchers have developed a novel drug for cancers associated with Epstein–Barr virus (EBV).
AstraZeneca vaccine arrives in Aus, Pfizer prevents infection
01 March, 2021The first doses of AstraZeneca's COVID-19 vaccine have arrived in Sydney, and new data suggests that Pfizer's vaccine can reduce asymptomatic infections.
Second-gen lung-on-chip developed
26 February, 2021Scientists have created a second-generation lung-on-chip model with life-size dimension alveoli in a stretchable membrane, made of purely biological material.
Nanoparticles boost the immune system to fight cancer
23 February, 2021A new nanoparticle-based drug can boost the body's innate immune system and make it more effective at fighting off tumours, according to researchers.
TGA approves AstraZeneca vaccine, Pfizer doses arrive in Aus
16 February, 2021The TGA has granted provisional approval to AstraZeneca for its COVID-19 vaccine, one day after >142,000 doses of Pfizer's vaccine arrived at Sydney Airport.
A rift in the retina helps transplanted cells better integrate
15 February, 2021Researchers have found that removing a membrane that lines the back of the eye may improve the success rate for regrowing nerve cells damaged by blinding diseases.
Oral ketamine can be used to reduce chronic suicidality
10 February, 2021Within six weeks of treatment, 69% of participants achieved a clinical reduction in suicide ideation — and half noted significant improvement after treatment had ceased.
10m more COVID-19 vaccines for Aus; Russia's efficacy results
05 February, 2021The Australian Government acquires another 10 million doses of Pfizer and BioNTech's vaccine and Russia announces promising phase 3 trial results.
3D-printed stents deliver drugs for oesophageal cancer
05 February, 2021The stents' composition allows them to deliver up to 110 days of a sustained anticancer medication directly to the cancer site.
The antibiotic potential of CBD
03 February, 2021Researchers have shown that synthetic cannabidiol — better known as CBD — can kill the bacteria responsible for gonorrhoea, meningitis and Legionnaires' disease.
Novavax COVID-19 vaccine demonstrates 89.3% efficacy
31 January, 2021NVX-CoV2373, a protein-based COVID-19 vaccine candidate, has demonstrated efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.
